drugset / Trial / NCT05015361

A Trial of Efficacy and Safety of Remimazolam Tosilate for Injection in Local Anesthesia Assisted Sedation

NCT05015361

Phase 2 Completed 108 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the efficacy and safety of Remimazolam Tosilate for injection in local anesthesia assisted sedation, and to explore the dose range of remazolam toluenesulfonate for injection in local anesthesia assisted sedation.

Timeline

Start
2021-05-07
Primary completion
2021-06-18
Completion
2021-07-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule
Subject Remimazolam Small molecule

Indications

No indication recorded.